Urging increased Federal funding for juvenile (Type 1) diabetes research.
The source supplies the latest action, but no lifecycle stage.
Latest action (2 Feb 2007): Referred to the Subcommittee on Health.
What this bill does
This House Concurrent Resolution urges the federal government to increase its funding for research into juvenile (Type 1) diabetes. The resolution states that this increase should be in line with recommendations from the Diabetes Research Working Group, with the goal of finding a cure for the disease.
The bill specifically addresses juvenile (Type 1) diabetes, a chronic condition affecting over 1.3 million Americans, with thousands of new diagnoses each year, including children and adults. It notes that current treatments manage the disease but do not cure it, and do not prevent serious complications.
Introduced in the House of Representatives on January 4, 2007, the resolution was referred to the Committee on Energy and Commerce. It was then sent to the Subcommittee on Health on February 2, 2007. As a concurrent resolution, it expresses the sense of Congress, meaning it conveys an opinion or recommendation to the executive branch or other entities, rather than requiring the President's signature to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Declares that federal funding for diabetes research should be increased in accordance with the recommendations of the Diabetes Research Working Group so that a cure for juvenile diabetes can be found.
Timeline
2 Feb 2007
Referred to the Subcommittee on Health.
Common questions
- What does H.Con.Res. 4 do?
- This House Concurrent Resolution urges the federal government to increase its funding for research into juvenile (Type 1) diabetes. The resolution states that this increase should be in line with recommendations from the Diabetes Research Working Group, with the goal of finding a cure for the disease. The bill specifically addresses juvenile (Type 1) diabetes, a chronic condition affecting over 1.3 million Americans, with thousands of new diagnoses each year, including children and adults. It notes that current treatments manage the disease but do not cure it, and do not prevent serious complications. Introduced in the House of Representatives on January 4, 2007, the resolution was referred to the Committee on Energy and Commerce. It was then sent to the Subcommittee on Health on February 2, 2007. As a concurrent resolution, it expresses the sense of Congress, meaning it conveys an opinion or recommendation to the executive branch or other entities, rather than requiring the President's signature to become law.
- Has H.Con.Res. 4 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 4. Check the latest action and official source below.
- Who sponsored H.Con.Res. 4?
- H.Con.Res. 4 was sponsored by Rep. Green, Gene [D-TX-29] (D-TX), with 4 cosponsors.
- What's the latest action on H.Con.Res. 4?
- Referred to the Subcommittee on Health. (2 Feb 2007).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Green, Gene [D-TX-29]
Supporting the Local Radio Freedom Act.
Consumer Online Privacy and Disclosure Act
Consumer Online Privacy and Disclosure Act
E-Mail User Protection Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.